Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Organization of Teratology Information Specialists (OTIS) Vedolizumab Pregnancy Exposure Registry

Trial Profile

Organization of Teratology Information Specialists (OTIS) Vedolizumab Pregnancy Exposure Registry

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Mar 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Vedolizumab (Primary)
  • Indications Crohn's disease; Ulcerative colitis
  • Focus Adverse reactions
  • Sponsors Takeda
  • Most Recent Events

    • 09 Mar 2023 Status changed from active, no longer recruiting to completed.
    • 26 Oct 2022 According to Results presented at American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2022, Vedolizumab Pregnancy Exposure Registry is ongoing with formal statistical analysis planned once the study is completed in 2023.
    • 26 Oct 2022 Results of preliminary descriptive outcomes presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2022
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top